Medications for Chronic Idiopathic Constipation (CIC)
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Chronic Idiopathic Constipation (CIC).
Found 4 Approved Drugs for Chronic Idiopathic Constipation (CIC)
Lubiprostone
Brand Names
Amitza, Amitiza
Lubiprostone
Brand Names
Amitza, Amitiza
Form: Capsule
Method of administration: Oral
FDA approval date: January 31, 2006
Classification: Chloride Channel Activator
Lubiprostone capsules is a chloride channel activator indicated for the treatment of: chronic idiopathic constipation (CIC) in adults.
Linzess
Generic Name
Linaclotide
Linzess
Generic Name
Linaclotide
Form: Capsule
Method of administration: Oral
FDA approval date: September 08, 2012
Classification: Guanylate Cyclase-C Agonist
LINZESS is indicated for the treatment of: irritable bowel syndrome with constipation (IBS-C) in adults, chronic idiopathic constipation (CIC) in adults, functional constipation (FC) in pediatric patients 6 to 17 years of age LINZESS is a guanylate cyclase-C agonist indicated for treatment of: Irritable bowel syndrome with constipation (IBS-C) in adults. ( 1 ) Chronic idiopathic constipation (CIC) in adults. ( 1 ) Functional constipation (FC) in pediatric patients 6 to 17 years of age. ( 1 )
Motegrity
Generic Name
Prucalopride
Motegrity
Generic Name
Prucalopride
Form: Tablet
Method of administration: Oral
FDA approval date: December 14, 2018
Classification: Serotonin-4 Receptor Agonist
Prucalopride tablet is indicated for the treatment of chronic idiopathic constipation (CIC) in adults. Prucalopride tablet is a serotonin-4 (5-HT 4 ) receptor agonist indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
Trulance
Generic Name
Plecanatide
Trulance
Generic Name
Plecanatide
Form: Tablet
Method of administration: Oral
FDA approval date: February 21, 2017
Classification: Guanylate Cyclase-C Agonist
TRULANCE is indicated in adults for the treatment of: chronic idiopathic constipation (CIC)., irritable bowel syndrome with constipation (IBS-C). TRULANCE is a guanylate cyclase-C agonist indicated in adults for treatment of:, chronic idiopathic constipation (CIC). ( 1 ), irritable bowel syndrome with constipation (IBS-C). ( 1 )
Showing 1-4 of 4
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances